Inventor · Shanghai, CN

Yingxia Sang

9Patents

2h-index

17Co-inventors

44Inventor score

Filing activity: Jul 25, 2012 → Jul 5, 2023

Most-cited inventions

Patent	Title	Area	Cited by	Status
US8975400B2	2,3-dihydroimidazo[1, 2-c] pyrimidin-5(1 H)-one compounds use as LP-PLA2 inhibitors	Human Necessities	2	Active
US9815841B2	Compounds	Chemistry; Metallurgy	2	Active
US9051325B2	Bicyclic [5,6] imidazo pyrimodone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2	Human Necessities	0	Active
US11034696B2	Compounds for inhibiting LRRK2 kinase activity	Chemistry; Metallurgy	0	Active
US10975081B2	Substituted fused pyrazole compounds and their use as LRRK2 inhibitors	Chemistry; Metallurgy	0	Active
US11999719B2	Solid form of compound	Chemistry; Metallurgy	0	Active
US10858367B2	Compounds	Chemistry; Metallurgy	0	Active
US10618901B2	LRRK2 inhibitors for the treatment of Parkinson's disease	Human Necessities	0	Active
US9708330B2	2,3-dihydroimidazol[1,2-C]pyrimidin-5(1-H)-one based ipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitors	Human Necessities	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.